Keywords: ipsen, 9-month, sales, rise, 5m, french, drugmaker
Ipsen's 9-month sales rise 5.5% to $994.5M
Article | 12 November 2007
French drugmaker Ipsen's consolidated group sales for the first nine months of 2007 reached 687.2 million euros ($994.5 million), up 5.5% year-on-year, fuelled by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
